Clinical Trial Update: Safety and Immunogenicity Study of Rift Valley Fever Vaccine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and immunogenicity of a Rift Valley Fever vaccine; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rift Valley Fever

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Rift Valley Fever | Phase 2 | Status: COMPLETED | Results posted: 2017-07-14